Showing results (91-100 of 127) with videos related to
Sort By:
Pageof 13
Oncology|January 1, 1981
The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancyC B Vaughn, J L Chapman, M Garland, et al.Cancer Drug Delivery|January 1, 1985
Hepatic arterial and systemic chemotherapy for the treatment of primary and secondary malignancies of the liverC B Vaughn, J Chapman, J Zaks, et al.Cancer Investigation|January 1, 1987
Ferritin content in human cancerous and noncancerous colonic tissueC B Vaughn, R Weinstein, B Bond, et al.Journal of the Neurological Sciences|April 21, 2021
Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic strokeAshkan Mowla, Maryam Sharifian-Dorche, Sandhya Mehla, et al.The Journal of the Acoustical Society of America|September 1, 2022
Sounds to Astound: An acoustics outreach showJennifer K Whiting, Mark L Berardi, Aaron B Vaughn, et al.Diseases of the Colon and Rectum|June 18, 2002
Early experience with stapled hemorrhoidectomy in the United StatesMarc A Singer, José R Cintron, James W Fleshman, et al.Cancer Investigation|January 1, 1988
Locally advanced adenocarcinoma of the breast without distant metastasis treated with multimodal therapiesC B Vaughn, J Chapman, S S Chen, et al.Cancer|December 20, 2002
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group studySaul E Rivkin, Stephanie J Green, Danika Lew, et al.American Journal of Clinical Oncology|June 1, 1986
The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancerC B Vaughn, J Chapman, M Garland, et al.Molecular Biology of the Cell|May 4, 2007
The molecular mechanism of hepcidin-mediated ferroportin down-regulationIvana De Domenico, Diane McVey Ward, Charles Langelier, et al.Pageof 13